Related Experiment Video
Updated: Jul 5, 2025

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Ceftriaxone-induced encephalopathy in a patient with a normal renal function.
Audrius Zarauskas1, Bruno Rodrigues2, Vincent Alvarez3
1Internal Medicine, Hopital de Sion Centre Hospitalier du Valais Romand, Sion, Switzerland zarauskas.a@gmail.com.
Ceftriaxone-induced encephalopathy is a rare side effect, even in patients without kidney issues. This case report details a recovery after stopping the antibiotic, emphasizing the need for broader diagnostic consideration.
Area of Science:
- Neurology
- Pharmacology
- Infectious Diseases
Background:
- Ceftriaxone is a widely used cephalosporin antibiotic.
- Ceftriaxone-induced encephalopathy is a rare adverse effect, typically seen in patients with renal impairment.
- Neurological symptoms associated with ceftriaxone can be severe and fluctuating.
Observation:
- A case of a fit elderly woman with normal renal function is presented.
- The patient developed aphasia, loss of contact, and chorea-like tongue movements during ceftriaxone treatment for a urinary tract infection with bacteremia.
- Symptoms emerged on day 4 and were suspected as an adverse drug reaction by day 7.
Findings:
- Ceftriaxone-induced encephalopathy was diagnosed after excluding other causes.
- Complete neurological recovery occurred within 3 days of ceftriaxone discontinuation.
- This case challenges the traditional risk factors associated with ceftriaxone encephalopathy.
Implications:
- Clinicians should consider ceftriaxone encephalopathy even in patients without renal failure.
- Early recognition and discontinuation of ceftriaxone are crucial for patient recovery.
- Further research into the pathophysiology and broader clinical spectrum of ceftriaxone-induced encephalopathy is warranted.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Electroconvulsive Therapy

